These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6539202

  • 1. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients.
    Wildiers J, De Clercq E.
    Eur J Cancer Clin Oncol; 1984 Apr; 20(4):471-6. PubMed ID: 6539202
    [Abstract] [Full Text] [Related]

  • 2. Oral BVDU treatment of varicella and zoster in children with cancer.
    Benoit Y, Laureys G, Delbeke MJ, De Clercq E.
    Eur J Pediatr; 1985 Jan; 143(3):198-202. PubMed ID: 3987714
    [Abstract] [Full Text] [Related]

  • 3. [5-(2-bromovinyl)-2'-deoxyuridine therapy of herpes zoster diseases in patients with malignant primary diseases].
    Wutzler P, Wutke K, Bärwolff D, Reefschläger J.
    Z Gesamte Inn Med; 1988 Dec 01; 43(23):677-80. PubMed ID: 2854331
    [Abstract] [Full Text] [Related]

  • 4. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
    De Clercq E.
    Biochem Pharmacol; 2004 Dec 15; 68(12):2301-15. PubMed ID: 15548377
    [Abstract] [Full Text] [Related]

  • 5. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
    de Clercq E, Degreef H, Wildiers J, de Jonge G, Drochmans A, Descamps J, de Somer P.
    Br Med J; 1980 Nov 01; 281(6249):1178. PubMed ID: 7427624
    [No Abstract] [Full Text] [Related]

  • 6. Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella-zoster virus infections in severely immunosuppressed patients: a preliminary clinical trial.
    Tricot G, De Clercq E, Boogaerts MA, Verwilghen RL.
    J Med Virol; 1986 Jan 01; 18(1):11-20. PubMed ID: 3511181
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    De Clercq E, Descamps J, Ogata M, Shigeta S.
    Antimicrob Agents Chemother; 1982 Jan 01; 21(1):33-8. PubMed ID: 6282207
    [Abstract] [Full Text] [Related]

  • 8. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
    de Clercq E, Zhang ZX, Sim IS.
    Antimicrob Agents Chemother; 1982 Sep 01; 22(3):421-5. PubMed ID: 7137983
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Sim IS.
    J Antimicrob Chemother; 1984 Aug 01; 14 Suppl A():111-8. PubMed ID: 6541647
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapy of Herpes zoster infections.
    Hirsch MS.
    Eur J Cancer Clin Oncol; 1984 Jul 01; 20(7):871-2. PubMed ID: 6540187
    [No Abstract] [Full Text] [Related]

  • 13. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    De Clercq E.
    Med Res Rev; 2005 Jan 01; 25(1):1-20. PubMed ID: 15389733
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C, Cool V, Baudson N, Degrève B, Balzarini J, De Leval L, Debrus S, Velu T, Calberg-Bacq CM.
    Cancer Gene Ther; 2000 Feb 01; 7(2):215-23. PubMed ID: 10770629
    [Abstract] [Full Text] [Related]

  • 15. Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Shigeta S, Yokota T, De Clercq E.
    Antiviral Res; 1985 Feb 01; Suppl 1():35-44. PubMed ID: 3002264
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
    Maudgal PC, De Clercq E, Missotten L.
    Antiviral Res; 1984 Oct 01; 4(5):281-91. PubMed ID: 6335020
    [Abstract] [Full Text] [Related]

  • 17. Bromovinyldeoxyurdine treatment of outer retinal necrosis due to varicella-zoster virus: a case-report.
    Dullaert H, Maudgal PC, Leys A, Dralands L, Clercq E.
    Bull Soc Belge Ophtalmol; 1996 Oct 01; 262():107-13. PubMed ID: 9339038
    [Abstract] [Full Text] [Related]

  • 18. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study.
    Wassilew SW, Wutzler P, Brivddin Herpes Zoster Study Group.
    Antiviral Res; 2003 Jun 01; 59(1):49-56. PubMed ID: 12834860
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.